RxSugar® and SiPhox Health Partner to Combat the Epidemic of Diet-related Disease
BURLINGTON, Mass., May 7, 2024 /PRNewswire/ -- RxSugar® and SiPhox Health are partnering to deliver solutions to combat the epidemic of diet-related disease.
- BURLINGTON, Mass., May 7, 2024 /PRNewswire/ -- RxSugar® and SiPhox Health are partnering to deliver solutions to combat the epidemic of diet-related disease.
- SiPhox Health is a well-recognized industry leader in the development of home biomarker testing solutions.
- Extensive research, including non-clinical and human studies, substantiates Allulose's significant role in vital physiological functions pertinent to cardiometabolic health [references].
- The SiPhox platform allows members to routinely test a wide array of traditional biomarkers providing a holistic snapshot of their comprehensive health and risk of disease.